89bio Inc [ETNB] stock prices are up 2.74% to $10.11 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ETNB shares have gain 6.53% over the last week, with a monthly amount glided 24.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
89bio Inc [NASDAQ: ETNB] stock has seen the most recent analyst activity on March 14, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $11. Previously, Citigroup started tracking the stock with Buy rating on March 13, 2025, and set its price target to $25. On February 04, 2025, Wolfe Research initiated with a Outperform rating. RBC Capital Mkts downgraded its rating to a Sector Perform and reduced its price target to $15 on January 12, 2024. Oppenheimer downgraded its rating to Perform for this stock on October 10, 2023. In a note dated August 28, 2023, UBS initiated an Buy rating and provided a target price of $36 on this stock.
The stock price of 89bio Inc [ETNB] has been fluctuating between $4.16 and $11.84 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $10.11 at the most recent close of the market. An investor can expect a potential return of 117.61% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -19204.19%, Pretax Profit Margin comes in at -18378.14%, and Net Profit Margin reading is -18413.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -0.81 and Total Capital is -0.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.87 points at the first support level, and at 9.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.33, and for the 2nd resistance point, it is at 10.56.
Ratios To Look Out For
It’s worth pointing out that 89bio Inc [NASDAQ:ETNB]’s Current Ratio is 18.03. On the other hand, the Quick Ratio is 18.03, and the Cash Ratio is 8.33.
Transactions by insiders
Recent insider trading involved Le-Nguyen Quoc, that happened on Apr 15 ’25 when 15329.0 shares were sold. Officer, QUOC LE-NGUYEN completed a deal on Apr 15 ’25 to buy 15329.0 shares. Meanwhile, Director RA CAPITAL MANAGEMENT, L.P. bought 5.71 million shares on Jan 30 ’25.
